Skygomet-PG1 Tablet ER

Overview Skygomet-PG1 Tablet ER

GlucoBalance ER is a dual-action tablet formulated to manage blood glucose. Used alongside diet and exercise, it improves glycemic control in adults with type 2 diabetes. Its mechanism enhances insulin effectiveness, resulting in reduced blood sugar. Always adhere to your physician's prescribed dosage and frequency. Take with food to minimize gastrointestinal discomfort. If a dose is missed, take it immediately; however, if the next dose is imminent, omit the missed dose and resume your regular schedule. Never double the dose. Overdosing can cause dangerously low blood sugar (hypoglycemia). Concurrent use with other diabetes medications, alcohol, or skipped meals may increase hypoglycemia risk; regular blood glucose monitoring is essential. Common side effects may include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Consult your doctor prior to use if you have kidney, liver, or heart conditions, or if you are pregnant or breastfeeding. Pre-treatment kidney function tests are typically required. Limit alcohol consumption as it may heighten the risk of adverse effects.

Uses of Skygomet-PG1 Tablet ER

Managing Type 2 Diabetes

Major Benefits of Skygomet-PG1 Tablet ER:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the Skygomet-PG1 Tablet ER whole; avoid chewing, crushing, or fracturing it. It should be taken with food.

Common Side effects of Skygomet-PG1 Tablet ER:

• Hypoglycemia (low blood glucose level)
• Headache
• Nausea
• Diarrhea
• Dizziness
• Vomiting
• Anemia (low number of red blood cells)
• Weakness
• Sinus infection

How to use Skygomet-PG1 Tablet ER:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Skygomet-PG1 Tablet ER whole; avoid chewing, crushing, or breaking it. Administer this medicine with food.

How Skygomet-PG1 Tablet ER works:

Skygomet-PG1 Extended-Release tablets contain a triple-action formulation addressing type 2 diabetes. This combination therapy unites glimepiride (a sulfonylurea), metformin (a biguanide), and pioglitazone (a thiazolidinedione). Each component employs a distinct mechanism to optimize blood glucose management, offering a superior alternative when single or dual-agent treatments prove inadequate. Glimepiride stimulates pancreatic insulin release, reducing blood sugar levels. Metformin acts on multiple fronts: decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness. Pioglitazone further amplifies insulin sensitivity.

What if you forget to take Skygomet-PG1 Tablet ER :

Should you forget a Skygomet-PG1 Tablet ER dose, take it promptly. Nevertheless, if your next dose is imminent, omit the missed one and resume your usual dosing regimen. Avoid taking a double dose.